Please assess the completion status of the following clinical trial:

Trial Title: Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who start EYLEA treatment for Diabetic Macular Edema (DME)~Exclusion Criteria:~* Patients who have already received EYLEA treatment

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aflibercept (Eylea,BAY86-5321) (Type: None): Decision of EYLEA treatment is made by attending investigator according to the Japanese Package Insert

Based on this trial design, predict the completion outcome and termination type (if applicable).